ketorolac tromethamine

Key facts

INN

ketorolac tromethamine

Brand

ACULAR LS

Route

NASAL

Formulation

SOLUTION

Originator

Amphastar Pharmaceuticals

Related patents

patent

US 12344842

Compositions and methods for treating and preventing macular degeneration

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12116622

Methods of associating genetic variants with a clinical outcome in patients suff

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12097188

Compositions and methods for the treatment of macular degeneration

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12084515

Compositions and methods for treatment of diabetic macular edema

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11969401

Compositions and methods for treating or limiting development of age-related mac

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11769597

Methods of associating genetic variants with a clinical outcome in patients suff

Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11519020

Methods of associating genetic variants with a clinical outcome in patients suff

Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11046785

Compositions and methods for treatment of diabetic macular edema

Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is ketorolac tromethamine?

ketorolac tromethamine (ACULAR LS), is a pharmaceutical active ingredient, associated with Amphastar Pharmaceuticals, with approved status in the US.

What is the brand name for ketorolac tromethamine?

ACULAR LS is a marketed brand name for ketorolac tromethamine. Check FDA Drugs@FDA for the current US label holder.